BASI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Bioanalytical Systems Inc's quarterly additional paid-in capital increased from Dec. 2013 ($22.03 Mil) to Mar. 2014 ($23.05 Mil) but then declined from Mar. 2014 ($23.05 Mil) to Jun. 2014 ($21.13 Mil).
Bioanalytical Systems Inc's annual additional paid-in capital increased from Sep. 2011 ($20.29 Mil) to Sep. 2012 ($21.51 Mil) and increased from Sep. 2012 ($21.51 Mil) to Sep. 2013 ($21.81 Mil).
Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.
Additional Paid-In Capital is calculated as
|Additional Paid-In Capital||=||(Issue Price||-||Par Value)||*||Shares Outstanding|
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Bioanalytical Systems Inc Annual Data
Bioanalytical Systems Inc Quarterly Data